Albumin and Machine Learning Model for Predicting 28-day All-cause Mortality in ICU Patients with Lung Cancer.
1/5 보강
PICO 자동 추출 (휴리스틱, conf 2/4)
유사 논문P · Population 대상 환자/모집단
274 patients, the 28-day mortality rate was 26.
I · Intervention 중재 / 시술
추출되지 않음
C · Comparison 대조 / 비교
추출되지 않음
O · Outcome 결과 / 결론
Among 1,274 patients, the 28-day mortality rate was 26.9%. Lower serum albumin levels were independently associated with higher 28-day mortality.
Serum albumin reflects nutritional status, systemic inflammation, and disease burden.
- p-value p = 0.002
- p-value p < 0.0001
- 95% CI 0.597-0.891
- 연구 설계 cohort study
APA
Zeng X, Zhang Y, et al. (2026). Albumin and Machine Learning Model for Predicting 28-day All-cause Mortality in ICU Patients with Lung Cancer.. Journal of visualized experiments : JoVE(230). https://doi.org/10.3791/70067
MLA
Zeng X, et al.. "Albumin and Machine Learning Model for Predicting 28-day All-cause Mortality in ICU Patients with Lung Cancer.." Journal of visualized experiments : JoVE, no. 230, 2026.
PMID
42008407
DOI
10.3791/70067
Abstract
Serum albumin reflects nutritional status, systemic inflammation, and disease burden. However, its prognostic significance in critically ill patients with lung cancer remains unclear. This study aimed to investigate the association between serum albumin and 28-day all-cause mortality in intensive care unit (ICU) patients with lung cancer and to assess its predictive value in machine learning (ML) models. This retrospective cohort study included 1,274 adult ICU patients with lung cancer from the Medical Information Mart for Intensive Care IV (MIMIC-IV) database. Multivariable Cox proportional hazards models evaluated the association between serum albumin and 28-day mortality. Additional analyses included restricted cubic splines, Kaplan-Meier survival curves, and subgroup analyses. ML classifiers were developed using the least absolute shrinkage and selection operator (LASSO) and Boruta for feature selection. Logistic regression was selected as the optimal model, with SHapley Additive Explanations (SHAP) values used for interpretation. Among 1,274 patients, the 28-day mortality rate was 26.9%. Lower serum albumin levels were independently associated with higher 28-day mortality. The hazard ratio for each 1 g/dL increase in serum albumin was 0.729 (95% CI, 0.597-0.891; p = 0.002). An inverse association was observed across serum albumin quartiles (p for trend <0.001), and Kaplan-Meier analysis showed lower mortality among patients with albumin ≥2.9 g/dL (log-rank p < 0.0001). The logistic regression model achieved an AUC of 0.767 in the validation cohort, indicating good discrimination and calibration. SHAP analysis identified serum albumin as a key predictor of 28-day mortality. Lower serum albumin was independently associated with increased short-term mortality in ICU patients with lung cancer. Serum albumin may serve as a practical biomarker for early risk stratification in this population. ML models incorporating albumin demonstrated strong predictive performance and interpretability.
MeSH Terms
Humans; Lung Neoplasms; Female; Male; Machine Learning; Middle Aged; Serum Albumin; Intensive Care Units; Aged; Retrospective Studies
같은 제1저자의 인용 많은 논문 (5)
- Pan-Cancer Analysis of CLDN3 and Its Contribution to 5-FU Resistance in Colorectal Cancer.
- METTL16 antagonizes astaxanthin-induced ferroptosis in colorectal cancer cells.
- Protein Scaffold DNA-Cu Functional Nanostructure Enable Rapid One-Pot Visual Portable Adaptable Aptasensing.
- Preparation and Antitumor Activity Evaluation of Folic Acid-Modified Phospholipid-Gambogic Acid Nanocrystals.
- MC1R contributes to ferroptosis resistance and tumor aggressiveness in colorectal cancer by activating Notch signaling.